<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="18366">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01974310</url>
  </required_header>
  <id_info>
    <org_study_id>MH-FDP-non-FDP</org_study_id>
    <nct_id>NCT01974310</nct_id>
  </id_info>
  <brief_title>Postoperative Positioning After Surgery for Macular Holes</brief_title>
  <official_title>A Randomized Clinical Trial of Face-down Protocol Versus Non-face-down Protocol After Surgery for Macular Holes.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Glostrup University Hospital, Copenhagen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Glostrup University Hospital, Copenhagen</source>
  <oversight_info>
    <authority>Denmark: Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Idiopathic macular holes are an important cause of visual loss. Macular holes can be treated
      by surgically removing the vitreous gel and injecting intraocular gas. Following macular
      hole surgery, face-down positioning is often advised with the aim of improving the
      likelihood of macular hole closure. The current evidence of postoperative positioning
      protocols is insufficient to draw firm conclusions and guide practice. The investigators
      wish to compare non-face-down positioning and face-down positioning after surgery for
      macular holes in a randomized trial.

      Hypothesis: Non-face-down positioning is equivalent to face-down positioning after surgery
      for macular holes.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2013</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Macular hole closure rate</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Macular hole closure rate assessed by optical coherence tomography</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>ETDRS Visual Acuity Gain</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Degree of postoperative head incline</measure>
    <time_frame>3 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>Position Sensor</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Degree of ocular gas fill</measure>
    <time_frame>4 days</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <other_outcome>
    <measure>Frequency of the complications</measure>
    <time_frame>During 3 months</time_frame>
    <safety_issue>Yes</safety_issue>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">68</enrollment>
  <condition>Macular Holes</condition>
  <arm_group>
    <arm_group_label>Face-down positioning</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients advised face-down positioning after surgery for macular hole.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-face-down positioning</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients advised non-face-down positioning after surgery for macular hole.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Vitrectomy &amp; Intraocular gas fill</intervention_name>
    <arm_group_label>Face-down positioning</arm_group_label>
    <arm_group_label>Non-face-down positioning</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Postoperative face-down positioning</intervention_name>
    <arm_group_label>Face-down positioning</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Idiopathic macular hole stage II-IV

          -  Informed consent

          -  Duration of symptoms ≤ 24 months

        Exclusion Criteria:

          -  Previous vitreomacular surgery

          -  Myopia ≥ 8 diopters

          -  Ocular trauma

          -  Disease affecting visual function (proliferative diabetic retinopathy, diabetic
             macular edema, exudative macular degeneration)
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Morten la Cour, Professor</last_name>
    <role>Study Director</role>
    <affiliation>Glostrup University Hospital, Copenhagen</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mark Alberti, BSc.med.</last_name>
    <phone>+45 51925195</phone>
    <email>mark.jensen.alberti@regionh.dk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Glostrup Hospital, University of Copenhagen</name>
      <address>
        <city>Copenhagen</city>
        <zip>2600</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Mark Alberti, BSc.med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>October 2013</verification_date>
  <lastchanged_date>October 31, 2013</lastchanged_date>
  <firstreceived_date>October 26, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Glostrup University Hospital, Copenhagen</investigator_affiliation>
    <investigator_full_name>Mark Alberti</investigator_full_name>
    <investigator_title>BSc.med.</investigator_title>
  </responsible_party>
  <keyword>Macular Holes</keyword>
  <keyword>Non face down positioning</keyword>
  <keyword>Face down positioning</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Retinal Perforations</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
